This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Astellas Pharma Gmbh. Active years: 2010-2014.
Company Filing History:
Years Active: 2010-2014
Title: The Innovative Contributions of Yoshihiro Kozuki
Introduction
Yoshihiro Kozuki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of 2 patents, his work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Kozuki's latest patents include a novel heterocyclic compound designed to treat rejection reactions in organ transplantation, as well as allergy diseases, autoimmune diseases, and hematologic tumors. This compound operates through a PI3Kδ selective inhibitory action, an IL-2 production inhibitory action, and a B cell proliferation inhibitory action. Additionally, he has developed pyrazinyl hydroxyacrylamide compounds that serve as histone deacetylase (HDAC) inhibitors. These compounds and their pharmaceutically acceptable salts are aimed at treating and preventing HDAC-related diseases.
Career Highlights
Yoshihiro Kozuki is currently employed at Astellas Pharma GmbH, where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic solutions.
Collaborations
Kozuki collaborates with esteemed colleagues such as Toru Asano and Hidehiko Fukahori, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yoshihiro Kozuki's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in addressing complex health challenges. His patents reflect a dedication to advancing medical science and improving patient care.